慢性閉塞性肺疾患を発症する生涯リスク:縦断的な集団研究
Andrea S Gershon1, Laura Warner, Paul Cascagnette
1Institute for Clinical Evaluative Sciences, Toronto, ON, Canada. andrea.gershon@ices.on.ca
Lancet (London, England)
|September 13, 2011
まとめ
約27.6%の個人が生涯にわたって慢性阻害性肺疾患 (COPD) と診断されます. この研究は,北米の多様な人口集団におけるCOPDのリスクを定量化しています.
科学分野:
- 肺内医学 肺内医学 肺内医学
- エピデミオロジー エピデミオロジー
- 公衆衛生は公衆衛生である.
背景:
- 慢性阻害性肺疾患 (COPD) は,死亡の主な原因であり,高い罹患率と重大な医療費がかかっています.
- 一般集団におけるCOPDの全生涯リスクの包括的な推定値は,以前は利用できませんでした.
研究 の 目的:
- 医者が診断したCOPDを発症する生涯リスクを定量化するために.
- 大規模で多文化的な北米の人口におけるCOPDのリスクを分析するために.
主な方法:
- カナダのオンタリオ州の保健行政データを利用した遡及的縦断コホート研究 (約. 1300万人の個体).
- COPDの診断,80歳,または死亡のために,最大14年間,1996年にCOPDのない個人のモニタリング.
- 医療サービスの主張に基づいてCOPDの検証された症例定義を使用し,競合するリスクに調整された累積的な発生率に対する生存分析を修正しました.
主要な成果:
- 80歳までに医師が診断したCOPDの生涯全体のリスクは27.6%でした.
- 生涯リスクは,人口統計によって異なる:男性 (29.7%) と女性 (25.6%),社会経済的地位が低い (32.1%) と高い (23.0%) と,農村 (32.4%) と都市 (26.7%) の環境でより高い.
- 研究期間中に,合計579,466人の個人がCOPDの診断を受けた.
結論:
- 約4人に1人が生涯にわたってCOPDと診断される.
- 証拠に基づいた臨床戦略,公衆衛生イニシアチブ,およびCOPDを予防し,患者の生活の質を改善するためのさらなる研究の必要性を強調します.
関連する概念動画
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation

